1
TITLE: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)  Full Text
AUTHORS: Veronique Crutel; Estelle Lambert; Pierre Francois Penelaud; Cristina Albarran Severo; Joaquin Fuentes; Antoine Rosier; Amaia Hervas; Stephane Marret; Guiomar Oliveira; Mara Parellada; Simon Kyaga; Sylvie Gouttefangeas; Marianne Bertrand; Denis Ravel; Bruno Falissard;
PUBLISHED: 2020, SOURCE: JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
INDEXED IN: Scopus WOS